Pudafensine

N/A

Report date: 2026/02/06 20:01:23
NME

Base Information

Drug NamePudafensine
Drug Alias NameIP-2015IPNP-2015IP-2017IPNP-2021IPED-2015 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine reuptake inhibitorsAdrenergic receptors modulatorsSerotonin reuptake inhibitors
TargetsDopamine transporterAdrenergic receptorsSerotonin transporter
Therapy Area/IndicationsPainVulvodyniaErectile Dysfunction +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwedenUnited Kingdom
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesInitiator Pharma
China Registration ClassN/A

Develop Information

Active CompaniesInitiator Pharma
Inactive CompaniesN/A
Active IndicationsPainVulvodyniaErectile Dysfunction +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A